Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ovid Therapeutics Inc.

    NASDAQ: OVID · Real-Time Price · USD
    0.32
    0.01 (2.14%)
    At close: Jun 06, 2025, 3:59 PM
    0.33
    3.71%
    After-hours: Jun 06, 2025, 05:58 PM EDT

    Ovid Therapeutics Statistics

    Share Statistics

    Ovid Therapeutics has 71.11M shares outstanding. The number of shares has increased by 0.18% in one year.

    Shares Outstanding

    n/a
    		 71.11M

    Shares Change (YoY)

    n/a
    		 0.18%

    Shares Change (QoQ)

    n/a
    		 0.09%

    Owned by Institutions (%)

    n/a
    		 67.02%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 195

    FTD / Avg. Volume

    n/a
    		 0.04%

    Short Selling Information

    The latest short interest is 1.63M, so 2.29% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.63M

    Short % of Shares Out

    n/a
    		 2.29%

    Short % of Float

    n/a
    		 2.74%

    Short Ratio (days to cover)

    n/a
    		 4.85

    Valuation Ratios

    The PE ratio is -2.5 and the forward PE ratio is -0.47. Ovid Therapeutics's PEG ratio is 0.05.

    PE Ratio

    n/a
    		 -2.5

    Forward PE

    n/a
    		 -0.47

    PS Ratio

    n/a
    		 116.97

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 0.97

    P/FCF Ratio

    n/a
    		 -1.18

    PEG Ratio

    n/a
    		 0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ovid Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.22.

    Current Ratio

    n/a
    		 5.32

    Quick Ratio

    n/a
    		 5.32

    Debt / Equity

    n/a
    		 0.22

    Debt / EBITDA

    n/a
    		 -0.24

    Debt / FCF

    n/a
    		 -0.26

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $24,608.7

    Profits Per Employee

    n/a
    		 $-1,149,260.87

    Employee Count

    n/a
    		 23

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -90% in the last 52 weeks. The beta is 0.07, so Ovid Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.07

    52-Week Price Change

    n/a
    		 -90%

    50-Day Moving Average

    n/a
    		 0.3

    200-Day Moving Average

    n/a
    		 0.78

    Relative Strength Index (RSI)

    n/a
    		 53.65

    Average Volume (20 Days)

    n/a
    		 457,882

    Income Statement

    In the last 12 months, Ovid Therapeutics had revenue of 566K and earned -26.43M in profits. Earnings per share was -0.37.

    Revenue

    n/a
    		 566K

    Gross Profit

    n/a
    		 566K

    Operating Income

    n/a
    		 -61.88M

    Net Income

    n/a
    		 -26.43M

    EBITDA

    n/a
    		 -61.27M

    EBIT

    n/a
    		 -61.88M

    Earnings Per Share (EPS)

    n/a
    		 -0.37
    Full Income Statement

    Balance Sheet

    The company has 26.3M in cash and 14.76M in debt, giving a net cash position of 11.55M.

    Cash & Cash Equivalents

    n/a
    		 26.3M

    Total Debt

    n/a
    		 14.76M

    Net Cash

    n/a
    		 11.55M

    Retained Earnings

    n/a
    		 -304.3M

    Total Assets

    n/a
    		 81.65M

    Working Capital

    n/a
    		 36.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -55.96M and capital expenditures -71K, giving a free cash flow of -56.03M.

    Operating Cash Flow

    n/a
    		 -55.96M

    Capital Expenditures

    n/a
    		 -71K

    Free Cash Flow

    n/a
    		 -56.03M

    FCF Per Share

    n/a
    		 -0.79
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -10933.75% and -4670.14%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -10933.75%

    Pretax Margin

    n/a
    		 -4670.14%

    Profit Margin

    n/a
    		 -4670.14%

    EBITDA Margin

    n/a
    		 -10825.27%

    EBIT Margin

    n/a
    		 -10933.75%

    FCF Margin

    n/a
    		 -9898.76%

    Dividends & Yields

    OVID does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for OVID is $3, which is 867.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 867.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.58

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist